ISTH guidelines for antithrombotic treatment in COVID-19: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Michelle S Chew; Klaus T Olkkola; Maija-Liisa Kalliomäki; Marius Rehn; Martin Ingi Sigurðsson; Morten Hylander Møller

doi:10.1111/aas.14259

ISTH guidelines for antithrombotic treatment in COVID-19: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Acta Anaesthesiol Scand. 2023 Sep;67(8):1118-1120. doi: 10.1111/aas.14259. Epub 2023 May 17.

Authors

Michelle S Chew¹, Klaus T Olkkola², Maija-Liisa Kalliomäki³, Marius Rehn⁴, Martin Ingi Sigurðsson^{5

6}, Morten Hylander Møller^{7

8}

Affiliations

¹ Department of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
² Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
³ Department of Anaesthesia, Tampere University Hospital, Tampere, Finland.
⁴ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁵ Division of Anesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
⁶ Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
⁷ Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
⁸ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

PMID: 37318942
DOI: 10.1111/aas.14259

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the ISTH guidelines for antithrombotic treatment in COVID-19. This evidence-based guideline serves as a useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

Keywords: AGREE II; COVID-19; ISTH; anticoagulation; clinical practice guideline; thromboprophylaxis.

MeSH terms

Anesthesiologists
Anesthesiology*
COVID-19*
Critical Care
Fibrinolytic Agents / therapeutic use
Humans

Substances

Fibrinolytic Agents

Grants and funding

Scandinavian Society of Anaesthesiology and Intensive Care Medicine